Zobrazeno 1 - 10
of 991
pro vyhledávání: '"Georg Bartsch"'
Autor:
Igor Tsaur, Carmen Biegel, Kilian Gust, Tanja Huesch, Hendrik Borgmann, Maximilian P.J.K. Brandt, Martin Kurosch, Michael Reiter, Georg Bartsch, David Schilling, Axel Haferkamp
Publikováno v:
International Brazilian Journal of Urology, Vol 41, Iss 3, Pp 486-495 (2015)
ABSTRACTPurpose:In patients with penile cancer (PeCa) and increased risk of inguinal lymphatic dissemination, inguinal lymphadenectomy offers a direct histological staging as the most reliable tool for assessment of the nodal metastasic status and a
Externí odkaz:
https://doaj.org/article/41202e67a23c4d8989be148b3f21aa23
Autor:
Stefan Vallo, Martin Michaelis, Florian Rothweiler, Georg Bartsch, Kilian M. Gust, Dominik M. Limbart, Franz Rödel, Felix Wezel, Axel Haferkamp, Jindrich Cinatl, Jr
Publikováno v:
Translational Oncology, Vol 8, Iss 3, Pp 210-216 (2015)
Combination chemotherapy with gemcitabine and cisplatin in patients with metastatic urothelial cancer of the bladder frequently results in the development of acquired drug resistance. Availability of cell culture models with acquired resistance could
Externí odkaz:
https://doaj.org/article/9c2b97cad35547b2b00840b15cb88676
Autor:
Eva Juengel, Jasmina Makarević, Michael Reiter, Jens Mani, Igor Tsaur, Georg Bartsch, Axel Haferkamp, Roman A. Blaheta
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 4, Pp 291-300 (2014)
Inhibitors of the mammalian target of rapamycin (mTOR) have improved the treatment of renal cell carcinoma (RCC). However, chronic drug exposure may trigger resistance, limiting the utility of these agents. The metastatic behavior of RCC cells, susce
Externí odkaz:
https://doaj.org/article/fff53da712ce4e9790e0809b4b438f46
Autor:
Jasmina Makarević, Jochen Rutz, Eva Juengel, Silke Kaulfuss, Michael Reiter, Igor Tsaur, Georg Bartsch, Axel Haferkamp, Roman A Blaheta
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e105590 (2014)
Amygdalin, a natural compound, has been used by many cancer patients as an alternative approach to treat their illness. However, whether or not this substance truly exerts an anti-tumor effect has never been settled. An in vitro study was initiated t
Externí odkaz:
https://doaj.org/article/73bf579315dc4dc8aa9c4d5db748b706
Autor:
Jens Mani, Jasmina Makarević, Eva Juengel, Hanns Ackermann, Karen Nelson, Georg Bartsch, Axel Haferkamp, Roman A Blaheta
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83709 (2013)
Scientists who are members of an editorial board have been accused of preferentially publishing their scientific work in the journal where they serve as editor. Reputation and academic standing do depend on an uninterrupted flow of published scientif
Externí odkaz:
https://doaj.org/article/4fcb0daef0cb435b8d3d0223b79da4e7
Autor:
Eva Juengel, Jasmina Makarević, Igor Tsaur, Georg Bartsch, Karen Nelson, Axel Haferkamp, Roman A Blaheta
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53100 (2013)
Targeted drugs have significantly improved the therapeutic options for advanced renal cell carcinoma (RCC). However, resistance often develops, negating the benefit of these agents. In the present study, the molecular mechanisms of acquired resistanc
Externí odkaz:
https://doaj.org/article/f157248cce14428dab16c66fa9c186c0
Autor:
Christian Thomas, Georg Bartsch, Christian Walter, Hendrik Borgmann, Maximilian Peter Brandt, Thomas Höfner, Axel Haferkamp, Igor Tsaur
Publikováno v:
Dentistry Journal, Vol 4, Iss 3, p 28 (2016)
Nine out of ten metastatic prostate cancer (PCa) patients will develop osseous metastases. Of these, every second will suffer from skeletal-related events (SRE). SRE are associated with an increased risk for death, which is markedly increased in the
Externí odkaz:
https://doaj.org/article/20f2fa2649024e97ba0073bc46e9ca62
Autor:
Georg Bartsch, Christian Thomas, Igor Tsaur, Marco Schnabel, Axel Haferkamp, Stanislav Gorbulev, Christian Ruckes, Kai Kronfeld
Publikováno v:
Journal of Clinical Oncology. 41:525-525
525 Background: Cabozantinib inhibits c-Met , AXL, RET, and VEGFR and has been FDA and EMA approved for the treatment of medullary thyroid cancer, hepatocellular carcinoma and renal cell carcinoma. In this trial (NCT04066595) we wanted to gain more i
Autor:
Christopher Netsch, Jens Mani, Georg Bartsch, Philipp Mandel, Christian Doehn, Anne-Karoline Ebert, Roswitha Siener
Publikováno v:
Uro-News. 23:14-28
Alljahrlich werden auf dem Kongress der Deutschen Gesellschaft fur Urologie (DGU) die neuesten Entwicklungen und Studiendaten vorgestellt. Sieben Experten haben fur ihr jeweiliges Fachgebiet die zentralen Erkenntnisse aus Hamburg zusammengefasst: Was
Autor:
Igor Tsaur, A. Neisius, D. Bon, Christian Thomas, Kilian M. Gust, Eva Herrmann, Maximilian Peter Brandt, Georg Bartsch, Axel Haferkamp
Publikováno v:
Andrology. 7:408-414
BACKGROUND Testicular germ cell tumor (TGCT) is one the most common solid tumors in men between the age of 15 and 35 with an overall incidence rate of 1-1.5 %. Epidemiologic studies have demonstrated different incidence patterns in western civilized